王玉英, 戚欣, 李静. 磷酸甘油酸激酶1与肿瘤J. 药学学报, 2019,54(6): 978-983. doi: 10.16438/j.0513-4870.2018-1101
引用本文: 王玉英, 戚欣, 李静. 磷酸甘油酸激酶1与肿瘤J. 药学学报, 2019,54(6): 978-983. doi: 10.16438/j.0513-4870.2018-1101
WANG Yu-ying, QI Xin, LI Jing. Phosphoglycerate kinase 1 and cancerJ. Acta Pharmaceutica Sinica, 2019,54(6): 978-983. doi: 10.16438/j.0513-4870.2018-1101
Citation: WANG Yu-ying, QI Xin, LI Jing. Phosphoglycerate kinase 1 and cancerJ. Acta Pharmaceutica Sinica, 2019,54(6): 978-983. doi: 10.16438/j.0513-4870.2018-1101

磷酸甘油酸激酶1与肿瘤

Phosphoglycerate kinase 1 and cancer

  • 摘要: 磷酸甘油酸激酶1(PGK1)是糖酵解过程中一个重要的催化酶,催化1,3-二磷酸甘油酸转变成3-磷酸甘油酸,产生一分子ATP。研究表明,PGK1在多种肿瘤中高表达,既可以作为蛋白激酶也可以作为代谢酶,通过影响肿瘤的代谢而影响肿瘤的发生发展过程,还与多种肿瘤患者的放化疗抵抗和预后不良有关。本文就其功能及与肿瘤的关系进行综述,旨在为靶向PGK1进行药物开发提供理论基础。

     

    Abstract: Phosphoglycerate kinase 1 (PGK1) is a key metabolic enzyme in the glycolysis pathway, which catalyzes the transfer of 1,3-bisphosphoglycerate (1,3-BPG) to 3-phosphoglycerate (3-PG) with ATP production. Over-expression of PGK1 has been observed in many types of malignance. Besides as a metabolic enzyme, PGK1 can also act as a protein kinase, which promotes the development and progression of tumors and correlates with chemoradiotherapy resistance and poor survival of cancer patients by regulating tumor cell metabolism. Functions of PGK1 were summarized in this article to provide theoretical basis for PGK1-targeting drug development.

     

/

返回文章
返回